Nintedanib Dosage
Medically reviewed by Drugs.com. Last updated on Jun 8, 2022.
Applies to the following strengths: 100 mg; 150 mg
Usual Adult Dose for:
Additional dosage information:
Usual Adult Dose for Idiopathic Pulmonary Fibrosis
150 mg orally every 12 hours
Maximum dose: 300 mg/day
Comments:
-Conduct liver function tests prior to initiating therapy.
-Conduct a pregnancy test in females of reproductive potential prior to initiating therapy.
Uses:
-For the treatment of idiopathic pulmonary fibrosis (IPF)
-To slow the rate of decline in pulmonary function in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD)
Usual Adult Dose for Chronic Lung Disease
150 mg orally every 12 hours
Maximum dose: 300 mg/day
Comments:
-Conduct liver function tests prior to initiating therapy.
-Conduct a pregnancy test in females of reproductive potential prior to initiating therapy.
Uses:
-For the treatment of idiopathic pulmonary fibrosis (IPF)
-To slow the rate of decline in pulmonary function in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD)
Renal Dose Adjustments
Mild to Moderate Renal Dysfunction (CrCl 30 to 90 mL/min): No adjustment recommended.
Severe Renal Dysfunction (CrCl less than 30 mL/min): Data not available
Liver Dose Adjustments
Mild Liver Dysfunction (Child-Pugh A): 100 mg orally 2 times a day; consider interruption or discontinuation of therapy for management of adverse reactions
Moderate or Severe Liver Dysfunction (Child-Pugh B or C): Not recommended.
AST or ALT elevation between 3 to 5 times the upper limit of normal (ULN) without signs of liver damage:
-Interrupt therapy or reduce the dose to 100 mg orally 2 times a day
-After return to baseline resume at 100 mg orally 2 times a day; if tolerated may return to full dose.
-Discontinue therapy if 100 mg orally 2 times a day is not tolerated.
Dose Adjustments
To manage severe side effects:
-Interrupt therapy or reduce the dose to 100 mg orally 2 times a day
-After resolution, resume at 100 mg orally 2 times a day; if tolerated may return to full dose.
-Discontinue therapy if 100 mg orally 2 times a day is not tolerated.
Precautions
CONTRAINDICATIONS:
-None
Safety and efficacy have not been established in patients younger than 18 years.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
-Take this drug with food.
-Swallow whole with liquid; do not chew or crush due to bitter taste.
-Advise patient to skip missed dose.
Storage requirements:
-Store at 25C (77F).
-Protect from exposure to high humidity and avoid excessive heat.
General:
-Increased risk of bleeding when used with anticoagulation therapy due to VEGFR inhibition.
-Conduct liver function tests prior to initiating therapy.
-Conduct a pregnancy test in females of reproductive potential prior to initiating therapy.
Monitoring:
-Hepatic: Liver function tests prior to treatment, monthly during first 3 months, and then every 3 months as clinically indicated.
Patient advice:
-Advise the patient to read the approved patient labeling.
More about nintedanib
- Side effects
- Drug interactions
- During pregnancy or Breastfeeding
- Reviews (6)
- En español
- Drug class: multikinase inhibitors
Patient resources
- Other brands
- Ofev
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.